UMB grants GlycoMantra exclusive license to advance company's therapeutic pipeline

GlycoMantra, a University of Maryland, Baltimore (UMB) startup company developing therapeutics for unmet medical needs in prostate cancer, NASH liver fibrosis, and type 2 diabetes, has been granted